_id
69105154ccc777a4e85d5451
Ticker
CMXCD
Name
CMXCD
Exchange
PINK
Address
123 West Nye Lane, Carson City, NV, United States, 89706
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://stimcell.com
Description
StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. It also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Cell MedX Corp. and changed its name to StimCell Energetics Inc. in November 2024. StimCell Energetics Inc. was incorporated in 2010 and is headquartered in Carson City, Nevada.
Last Close
0.355
Volume
102
Current Price
0.355
Change
-0.045
Last Updated
2025-11-09T08:31:15.079Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-05-31
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
261646
Operating Income
-261646
Interest Expense
11143
Pretax Income
-219329
Net Income
-219329
Eps
-0.010889530710870694
Dividends Per Share
-
Shares Outstanding
20141272
Income Tax Expense
-
EBITDA
-
Total Other Income Expense Net
-
Cash
14581
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
21222
Property Plant Equipment
-
Total Assets
21222
Payables
322144
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1267508
Equity
-1246286
Depreciation
-
Change In Working Capital
95894
Cash From Operations
-58448
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
66113
Net Change In Cash
7903
PE
-
PB
-5.737167520135827
ROE
17.598608987022242
ROA
-1033.4982565262462
FCF
-58448
Fcf Percent
-
Piotroski FScore
1
Health Score
37
Deep Value Investing Score
0.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
1.5
Growth Investing Score
1
Momentum Investing Score
5
Net Net Investing Score
0
Quality Investing Score
2
Value Investing Score
2.5
Quarters > 0 > quarter
2025-05-31
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
261646
Quarters > 0 > income Statement > operating Income
-261646
Quarters > 0 > income Statement > interest Expense
11143
Quarters > 0 > income Statement > pretax Income
-219329
Quarters > 0 > income Statement > net Income
-219329
Quarters > 0 > income Statement > eps
-0.010889530710870694
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
20141272
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > balance Sheet > cash
14581
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
21222
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
21222
Quarters > 0 > balance Sheet > payables
322144
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1267508
Quarters > 0 > balance Sheet > equity
-1246286
Quarters > 0 > cash Flow > net Income
-219329
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
95894
Quarters > 0 > cash Flow > cash From Operations
-58448
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
66113
Quarters > 0 > cash Flow > net Change In Cash
7903
Quarters > 0 > ratios > PE
-0.010889530710870694
Quarters > 0 > ratios > PB
-5.737167520135827
Quarters > 0 > ratios > ROE
17.598608987022242
Quarters > 0 > ratios > ROA
-1033.4982565262462
Quarters > 0 > ratios > FCF
-58448
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
37
Quarters > 1 > quarter
2025-02-28
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
89534
Quarters > 1 > income Statement > operating Income
-89534
Quarters > 1 > income Statement > interest Expense
9451
Quarters > 1 > income Statement > pretax Income
-140537
Quarters > 1 > income Statement > net Income
-140537
Quarters > 1 > income Statement > eps
-0.007091999948325296
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
19816272
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > balance Sheet > cash
6678
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
17110
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
17110
Quarters > 1 > balance Sheet > payables
310901
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
378174
Quarters > 1 > balance Sheet > total Liabilities
1087325
Quarters > 1 > balance Sheet > equity
-1070215
Quarters > 1 > cash Flow > net Income
-140537
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
46664
Quarters > 1 > cash Flow > cash From Operations
-43716
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
16745
Quarters > 1 > cash Flow > net Change In Cash
-27143
Quarters > 1 > ratios > PE
-0.007091999948325296
Quarters > 1 > ratios > PB
-6.573236742149941
Quarters > 1 > ratios > ROE
13.13166046074854
Quarters > 1 > ratios > ROA
-821.3734658094681
Quarters > 1 > ratios > FCF
-43716
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
33
Quarters > 2 > quarter
2024-11-30
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
79924
Quarters > 2 > income Statement > operating Income
-79924
Quarters > 2 > income Statement > interest Expense
8810
Quarters > 2 > income Statement > pretax Income
-139508
Quarters > 2 > income Statement > net Income
-139508
Quarters > 2 > income Statement > eps
-0.007040072925926733
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
19816272
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > balance Sheet > cash
33821
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
38346
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
38346
Quarters > 2 > balance Sheet > payables
316282
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
355777
Quarters > 2 > balance Sheet > total Liabilities
1021051
Quarters > 2 > balance Sheet > equity
-982705
Quarters > 2 > cash Flow > net Income
-139508
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
63615
Quarters > 2 > cash Flow > cash From Operations
-16519
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
13269
Quarters > 2 > ratios > PE
-0.007040072925926733
Quarters > 2 > ratios > PB
-7.15858427503676
Quarters > 2 > ratios > ROE
14.196325448634129
Quarters > 2 > ratios > ROA
-363.81369634381684
Quarters > 2 > ratios > FCF
-16519
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-08-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
73845
Quarters > 3 > income Statement > operating Income
-73845
Quarters > 3 > income Statement > interest Expense
8852
Quarters > 3 > income Statement > pretax Income
-66919
Quarters > 3 > income Statement > net Income
-66919
Quarters > 3 > income Statement > eps
-0.003377059812700579
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
19815758
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > balance Sheet > cash
20552
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
22397
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
22397
Quarters > 3 > balance Sheet > payables
311167
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
931127
Quarters > 3 > balance Sheet > equity
-908730
Quarters > 3 > cash Flow > net Income
-66919
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
51242
Quarters > 3 > cash Flow > cash From Operations
-22917
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-22863
Quarters > 3 > ratios > PE
-0.003377059812700579
Quarters > 3 > ratios > PB
-7.741126726310345
Quarters > 3 > ratios > ROE
7.364013513364806
Quarters > 3 > ratios > ROA
-298.78555163637986
Quarters > 3 > ratios > FCF
-22917
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
29
Valuation > metrics > PE
-0.010889530710870694
Valuation > metrics > PB
-5.737167520135827
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
17.598608987022242
Profitability > metrics > ROA
-1033.4982565262462
Profitability > final Score
50
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-23.480750246791708
Risk > final Score
-64
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.06587737161021158
Liquidity > metrics > Quick Ratio
0.06587737161021158
Liquidity > final Score
13
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
41
Prev Profitabilities > 1
43
Prev Profitabilities > 2
30
Prev Risks > 0
-8
Prev Risks > 1
-6
Prev Risks > 2
-3
Prev Liquidities > 0
13
Prev Liquidities > 1
16
Prev Liquidities > 2
14
Updated At
2026-01-20T21:37:39.732Z
StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. It also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Cell MedX Corp. and changed its name to StimCell Energetics Inc. in November 2024. StimCell Energetics Inc. was incorporated in 2010 and is headquartered in Carson City, Nevada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-05-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of CMXCD
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-05-31)
(Last Updated 2025-05-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
(Last Updated 2025-05-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-05-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.